The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 14, 2026
Filed:
Oct. 16, 2020
Applicant:
Cisen Pharmaceutical Co., Ltd, Jining, CN;
Inventors:
Ming Zhou, Shanghai, CN;
Zhaobing Xu, Shanghai, CN;
Gang Li, Shanghai, CN;
Lihong Hu, Shanghai, CN;
Charles Z. Ding, Shanghai, CN;
Wen Jiang, Shanghai, CN;
Guoping Hu, Shanghai, CN;
Jian Li, Shanghai, CN;
Shuhui Chen, Shanghai, CN;
Assignee:
CISEN PHARMACEUTICAL CO., LTD, Jining, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/519 (2006.01); A61P 35/00 (2006.01); C07D 471/10 (2006.01); C07D 487/04 (2006.01); C07D 487/10 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/519 (2013.01); A61P 35/00 (2018.01); C07D 471/10 (2013.01); C07D 487/04 (2013.01); C07D 487/10 (2013.01);
Abstract
Disclosed is an aminopyrimidine compound as a CDK2/4/6 inhibitor, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof, and an application of the compound represented by formula (I) and the pharmaceutically acceptable salt thereof in the preparation of a medicament for treating solid tumor.